Skip to main content
Edwin Rock, MD, Oncology, Bethesda, MD

EdwinPalmerRockMDPhD

Oncology • Bethesda, MD

Drug Development Consultant

Join to view full profile

Dr. Rock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rock's full profile

Already have an account?

  • Office

    5518 Lincoln St
    Bethesda, MD 20817
    Phone+1 609-356-9459
    Fax+1 240-514-3878

Summary

  • Edwin Rock, MD is an immunologist and medical oncologist that seeks to contribute to development of novel therapies that address unmet needs. He spent 11 years at the lab bench studying malaria vaccine candidates, structure-function relationships of antigen-specific immune receptors, and fertility regulating vaccines. After obtaining PhD and MD degrees at Stanford University School of Medicine, he trained in Internal Medicine at Brigham and Women's Hospital of Harvard Medical School, then worked for 18 months at Leerink Swann and Co, a life sciences investment bank. Realizing he would rather make new medicines than bet on them, he trained in Medical Oncology at the University of Pennsylvania before serving as a Medical Officer and oncology drug reviewer at the Food and Drug Administration. For the past 2 decades he has worked in the biopharma industry across molecular classes, disease indications, and development phases.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2004
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1998

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2002 - 2014
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Presented at ASH Annual Meeting
    GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Presented at ASH Annual MeetingDecember 12th, 2022
  • GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Will Be Presented at ASH Annual Meeting
    GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Will Be Presented at ASH Annual MeetingNovember 3rd, 2022
  • Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
    Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical OfficerSeptember 15th, 2020

Dr. Edwin Rock, Dr. Edwin Rock, MD, Dr. E Rock, Dr. Edwin Palmer Rock